Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review
A Jamnitski, D Symmons, MJL Peters… - Annals of the …, 2013 - ard.bmj.com
Objective Data regarding cardiovascular comorbidity and cardiovascular risk factors in
patients with psoriatic arthritis (PsA) are limited. To evaluate the cardiovascular risk profile, a …
patients with psoriatic arthritis (PsA) are limited. To evaluate the cardiovascular risk profile, a …
[HTML][HTML] The potential harm of oxygen therapy in medical emergencies
AD Cornet, AJ Kooter, MJL Peters, YM Smulders - Critical Care, 2013 - Springer
In medical emergencies, supplemental oxygen is often administrated routinely. Most paramedics
and physicians believe that high concentrations of oxygen are life-saving [ 1 ]. Over the …
and physicians believe that high concentrations of oxygen are life-saving [ 1 ]. Over the …
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
MJL Peters, VP van Halm, AE Voskuyl… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular
disease (CVD), but longitudinal observations are limited and the precise magnitude is …
disease (CVD), but longitudinal observations are limited and the precise magnitude is …
Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study
…, F Bäckhed, L Vogt, MJL Peters… - European heart …, 2020 - academic.oup.com
Aims Preliminary evidence from animal and human studies shows that gut microbiota
composition and levels of microbiota-derived metabolites, including short-chain fatty acids (SCFAs)…
composition and levels of microbiota-derived metabolites, including short-chain fatty acids (SCFAs)…
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
…, LA Aarden, SO Stapel, MJL Peters… - Annals of the …, 2009 - ard.bmj.com
Background: Immunogenicity, specifically the onset of antibodies against tumour necrosis
factor (TNF) blocking agents, seems to play an important role in non-response to treatment …
factor (TNF) blocking agents, seems to play an important role in non-response to treatment …
Erythrocyte sedimentation rate, C‐reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti–tumor necrosis factor treatment in …
…, IE van der Horst‐bruinsma, MJL Peters… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To study the usefulness of erythrocyte sedimentation rate (ESR), C‐reactive
protein (CRP), and serum amyloid A (SAA) for response prediction and monitoring of anti–tumor …
protein (CRP), and serum amyloid A (SAA) for response prediction and monitoring of anti–tumor …
Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis
MJL Peters, YVOM SMULDERS, E SERNE… - The Journal of …, 2010 - jrheum.org
Objective. Preliminary evidence suggests that ankylosing spondylitis (AS) is associated with
an increased cardiovascular (CV) risk. We investigated subclinical atherosclerosis and …
an increased cardiovascular (CV) risk. We investigated subclinical atherosclerosis and …
The effects of tumor necrosis factor inhibitors on cardiovascular risk in rheumatoid arthritis
M JL Peters, AM van Sijl, AE Voskuyl… - Current …, 2012 - ingentaconnect.com
There is abundant evidence that rheumatoid arthritis (RA), a chronic inflammatory disorder,
is associated with an increased risk for cardiovascular (CV) disease. While there may be …
is associated with an increased risk for cardiovascular (CV) disease. While there may be …
The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis
AM van Sijl, MJL Peters, DL Knol, RHC de Vet… - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVES: Changes in the lipid profile have been described in patients with rheumatoid
arthritis (RA) following therapy with tumor necrosis factor (TNF)-alpha blocking agents. …
arthritis (RA) following therapy with tumor necrosis factor (TNF)-alpha blocking agents. …
Improvement of lipid profile is accompanied by atheroprotective alterations in high‐density lipoprotein composition upon tumor necrosis factor blockade: a prospective …
…, MK de Vries, JHM Levels, MJL Peters… - Arthritis & …, 2009 - Wiley Online Library
Objective Cardiovascular mortality is increased in ankylosing spondylitis (AS), and
inflammation plays an important role. Inflammation deteriorates the lipid profile and alters high‐…
inflammation plays an important role. Inflammation deteriorates the lipid profile and alters high‐…